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Policy background 
One of Public Health England’s (PHE) priorities is to improve recovery rates from drug 
dependency. To achieve this, a commitment has been made to increase the number of 
areas that have fostered effective links between treatment services and relevant 
community and mutual aid groups with the aim of enhancing social integration and 
wellbeing.  
The importance of mutual aid in promoting and sustaining recovery from drug 
dependence is also highlighted within the government’s drug strategyi: “Active 
promotion and support of local mutual aid networks such as Alcoholics and Narcotics 
Anonymous will be essential.” 
 
About this briefing 
The role played by mutual aid in promoting and sustaining recovery from drug and 
alcohol problems has already been examined by the National Institute of Health and 
Care Excellence (NICE), the Recovery Orientated Drug Treatment Expert Group 
(RODT) and the Advisory Council on the Misuse of Drugs (ACMD). This briefing aims to 
bring these existing findings and recommendations on mutual aid together to increase 
their visibility and accessibility for the alcohol and drug treatment field.   
 
What is mutual aid? 
Mutual Aid refers to the social, emotional and informational support provided by, and to, 
members of a group at every stage of recovery. Groups often include people who are 
abstinent and want help to remain so – these people are actively changing their 
behaviour using a programme of mutual aid. They also include people who are thinking 
about stopping and/or actively trying to stop their drug and alcohol use. Groups also 
exist to support families, children and friends affected by substance misuse. 
The most common mutual aid groups in England include 12-step fellowships and 
SMART Recovery. The fellowships (eg, Alcoholics Anonymous (AA), Narcotics 
Anonymous (NA), Cocaine Anonymous (CA) and Al-Anon) are based on a 12-step self-
help philosophy developed in the 1930s. SMART Recovery applies cognitive 
behavioural techniques and therapeutic lifestyle change to its mutual aid groups to help 
people manage their recovery. 
 
NICE 
The NICE Quality Statement (QS23)ii for drug use disorders sets out what high-quality 
care should include, based on NICE drug misuse technology appraisals and clinical 
guidelines. It comprises ten quality statements, one of which recommends that people in 
drug treatment are offered support to access mutual aid organisations, which are 
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defined as including SMART (self-management and recovery training) Recovery and 
those based on 12-step principles, eg, NA, AA and CA.  
NICE Clinical Guidelines CG51iii on psychosocial interventions for drug misuse set out 
recommendations that are developed using systematic methods to identify and evaluate 
the best available evidence. 
Seven studies assessing the efficacy of 12-step self-help groups met the inclusion 
eligibility criteria and all were published in peer-reviewed journals. Based on this 
evidence their guideline recommendation was: 
“If a person who misuses drugs has expressed an interest in attending a 12-step 
self-help group, staff should consider facilitating the person's initial contact with the 
group, for example by making the appointment, arranging transport, accompanying 
him or her to the first session and dealing with any concerns.” 
NICE Clinical Guidelines CG115iv cover diagnosing, assessing and managing harmful 
drinking and alcohol dependence, setting out recommendations about the treatment and 
care of people with alcohol use disorders that are also developed using systematic 
methods to identify and evaluate the best available evidence. 
A systematic review of randomized controlled trials (RCTs) was undertaken and six 
trials met the eligibility criteria. All were published in peer-review journals between 1997 
and 2009. The guideline recommendation was: 
For all people seeking help for alcohol misuse: 
• give information on the value and availability of community support networks and 
self-help groups (eg, AA or SMART Recovery) 
• help them to participate in community support networks and self-help groups by 
encouraging them to go to meetings and arranging support so that they can 
attend 
 
‘Medications in recovery’, the report of the RODTv 
This key piece of drug treatment guidance, aimed at commissioners and providers of 
drug treatment, describes principles and prompts for re-orientating drug treatment 
towards recovery and helping more heroin users to recover and break free of 
dependence. This guidance was informed by a substantial scientific evidence base and 
developed by means of consensus among a group of experts in the drug treatment field, 
chaired by Professor John Strang.   
The report seeks “to use this knowledge to set a new benchmark for the English 
treatment system that is both radically ambitious and scientifically rigorous.” It highlights 
the benefits of mutual aid in strengthening community integration and developing 
recovery capital, and makes clear recommendations around promoting choice and 
facilitating access to mutual aid: 
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“Strengthen or develop patients’ social networks, involving families where 
appropriate and facilitating access to mutual aid by, for example, providing 
information, transport, or premises for meetings, and by bringing local recovery 
champions into the service to meet patients.” 
“Promote choice by ensuring people in treatment have a range of peer-support 
options including 12-step, SMART Recovery and other local peer-support services” 
Local areas are encouraged to build good relationships with mutual aid organisations to 
encourage the best possible range of accessible support for their local populations: 
“To optimise the benefits of self-help approaches it will be crucial that local areas 
develop good relationships with existing local mutual aid networks and other peer-
based recovery support groups and encourage the development of new local 
groups/services in the community and within the treatment population.” 
 
ACMD 
The ACMD recovery committee has been created as a standing committee of the 
ACMD to provide evidence-based advice to government on recovery from dependence 
on drugs and alcohol. Its second report “What recovery outcomes does the evidence tell 
we can expect?”vi welcomes the valuable role played in recovery by mutual aid, 
including AA, NA and SMART Recovery 
This report draws upon a wide range of international peer-reviewed evidence that 
demonstrates the efficacy and effectiveness of mutual aid. The evidence cited in this 
report demonstrates that:  
• involvement with mutual aid can significantly improve recovery outcomes  
• more active or frequent involvement, such as becoming a sponsor, is associated 
with greater improvement in outcomes 
• substance misuse treatment providers can improve sustained recovery outcomes 
(including abstinence) by actively encouraging service users to engage with 
mutual aid 
The report also highlights emerging evidence that a close match between personal 
beliefs and choice of mutual aid group attended improves outcomes and that non 12-
step groups are probably as effective as 12-step fellowships: 
“The large majority of mutual aid research is based on the ‘12 step’ or ‘fellowship’ 
approach that is practiced by Narcotics Anonymous and Alcoholics Anonymous. 
The vast majority of research evidence is from the USA and relates to these 
fellowships. There is emerging evidence on other forms of mutual aid, for example, 
SMART Recovery”. 
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The report concludes that further development of mutual aid in the UK should be 
encouraged in local communities by local commissioners, providers and other 
stakeholders. 
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